AstraZeneca (AZN) News Today GBX 9,999.56 +30.56 (+0.31%) (As of 07:07 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Insider Buying: AstraZeneca PLC (LON:AZN) Insider Buys 1,500 Shares of StockNovember 21 at 1:13 AM | insidertrades.comAstraZeneca PLC (LON:AZN) Receives £104.12 Average Price Target from AnalystsNovember 19 at 2:57 AM | americanbankingnews.comAstraZeneca PLC (LON:AZN) Insider Acquires £2,040,600 in StockNovember 18 at 1:13 AM | americanbankingnews.comAstraZeneca PLC (LON:AZN) Receives Average Rating of "Moderate Buy" from BrokeragesAstraZeneca PLC (LON:AZN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine brokerages that are currently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy raNovember 16, 2024 | marketbeat.comAstraZeneca PLC (LON:AZN) Insider Pascal Soriot Buys 20,000 SharesNovember 16, 2024 | insidertrades.comInsider Buying: AstraZeneca PLC (LON:AZN) Insider Buys 20,000 Shares of StockAstraZeneca PLC (LON:AZN - Get Free Report) insider Pascal Soriot purchased 20,000 shares of the firm's stock in a transaction on Thursday, November 14th. The shares were acquired at an average price of £102.03 ($131.30) per share, with a total value of £2,040,600 ($2,625,916.87).November 15, 2024 | marketbeat.comAstraZeneca put volume heavy and directionally bearishNovember 15, 2024 | markets.businessinsider.comAstraZeneca: Overcoming Short-term Challenges with Robust Long-term PotentialNovember 14, 2024 | markets.businessinsider.comAstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investmentsNovember 13, 2024 | msn.comAstraZeneca PLC (NASDAQ:AZN) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comBarclays Keeps Their Buy Rating on AstraZeneca (AZN)November 13, 2024 | markets.businessinsider.comAstraZeneca reports Q3 core EPS $2.08, consensus $1.03November 12, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: AstraZeneca (AZN) and Neurogene (NGNE)November 12, 2024 | markets.businessinsider.comAstraZeneca to spend $3.5B to expand U.S. operationsNovember 12, 2024 | seekingalpha.comAstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic RhinosinusitisNovember 8, 2024 | finance.yahoo.comAstraZeneca (LON:AZN) Given Overweight Rating at JPMorgan Chase & Co.JPMorgan Chase & Co. reissued an "overweight" rating and set a £140 ($182.24) target price on shares of AstraZeneca in a research note on Thursday.November 7, 2024 | marketbeat.comAstraZeneca extends losses as Chinese probe widensNovember 6, 2024 | msn.comTop AstraZeneca Executives Caught in Expanding China Probe, Shares Slide FurtherNovember 6, 2024 | finance.yahoo.comTD Cowen Sticks to Their Buy Rating for AstraZeneca (AZN)November 6, 2024 | markets.businessinsider.comAstraZeneca Falls Most Since 2020 as China Probe Fears MountNovember 5, 2024 | finance.yahoo.comAstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investorsNovember 5, 2024 | msn.comGoldman Sachs Reaffirms Their Buy Rating on AstraZeneca (AZN)November 5, 2024 | markets.businessinsider.comBarclays Reaffirms Their Buy Rating on AstraZeneca (AZN)November 5, 2024 | markets.businessinsider.comAstraZeneca Unveils Early Data From Chinese-Firm Partnered Oral Weight Loss DrugNovember 4, 2024 | msn.comAstraZeneca (AZN) Receives a Buy from J.P. MorganNovember 4, 2024 | markets.businessinsider.comAre Options Traders Betting on a Big Move in AstraZeneca (AZN) Stock?November 4, 2024 | msn.comMonopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic DisorderOctober 25, 2024 | benzinga.comAstraZeneca PLC (LON:AZN) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of AstraZeneca PLC (LON:AZN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the nine brokerages that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and siOctober 22, 2024 | marketbeat.comWith 72% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backingOctober 20, 2024 | finance.yahoo.comHere are the 2025 dividend forecasts for FTSE giants Unilever, GSK, and AstraZenecaOctober 14, 2024 | msn.comAstraZeneca PLC ADR remains steady Tuesday, underperforms marketOctober 9, 2024 | marketwatch.comAstraZeneca Seeks Expanded Use For Blood Cancer Drug Calquence, FDA Grants Priority ReviewOctober 3, 2024 | finance.yahoo.comIs AstraZeneca PLC (NASDAQ:AZN) The Top Global Stock To Buy Now?September 30, 2024 | finance.yahoo.comAstraZeneca PLC (LON:AZN) Given Consensus Recommendation of "Moderate Buy" by AnalystsAstraZeneca PLC (LON:AZN - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendSeptember 27, 2024 | marketbeat.comTop Stock Reports for Toyota, AstraZeneca & ChubbSeptember 27, 2024 | finance.yahoo.comAstraZeneca’s Market Position and Drug Pipeline Sustain Buy Rating Despite TB01 Trial ResultsSeptember 23, 2024 | markets.businessinsider.comLatest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails To Extend Lives Of Pretreated Breast Cancer PatientsSeptember 23, 2024 | finance.yahoo.comCould The Market Be Wrong About AstraZeneca PLC (LON:AZN) Given Its Attractive Financial Prospects?September 19, 2024 | finance.yahoo.comAstraZeneca: Strong Oncology Pipeline Fuels Growth and Outperformance – Buy Rating EndorsedSeptember 18, 2024 | markets.businessinsider.comBarclays Sticks to Its Buy Rating for AstraZeneca (AZN)September 17, 2024 | markets.businessinsider.comInsider Buying: AstraZeneca PLC (LON:AZN) Insider Buys £2,360 in StockSeptember 17, 2024 | insidertrades.comJPMorgan Chase & Co. Reaffirms Overweight Rating for AstraZeneca (LON:AZN)JPMorgan Chase & Co. restated an "overweight" rating on shares of AstraZeneca in a report on Monday.September 16, 2024 | marketbeat.comMichel Demare Buys 2,000 Shares of AstraZeneca PLC (LON:AZN) StockAstraZeneca PLC (LON:AZN - Get Free Report) insider Michel Demare purchased 2,000 shares of the company's stock in a transaction dated Friday, September 13th. The stock was purchased at an average price of GBX 118 ($1.54) per share, for a total transaction of £2,360 ($3,086.18).September 16, 2024 | marketbeat.comAstraZeneca (LON:AZN) Shares Pass Above Two Hundred Day Moving Average of $11,865.94AstraZeneca (LON:AZN) Share Price Crosses Above 200 Day Moving Average of $11,865.94September 11, 2024 | marketbeat.comAstraZeneca (LON:AZN) Stock Rating Reaffirmed by Deutsche Bank AktiengesellschaftDeutsche Bank Aktiengesellschaft restated a "hold" rating and set a £110 ($144.64) price target on shares of AstraZeneca in a research report on Tuesday.September 3, 2024 | marketbeat.comSeveral Reasons for the Outperformance of Astrazeneca Plc (AZN)September 3, 2024 | finance.yahoo.comAstraZeneca (LON:AZN) Reaches New 12-Month High at $13,372.00AstraZeneca (LON:AZN) Sets New 52-Week High at $13,372.00September 2, 2024 | marketbeat.comAstraZeneca (LON:AZN) Hits New 52-Week High at $13,238.00AstraZeneca (LON:AZN) Reaches New 12-Month High at $13,238.00August 27, 2024 | marketbeat.comAstraZeneca Threatens To Move Vaccine Production Amid Reduced State SupportAugust 23, 2024 | msn.comAstraZeneca Says FDA Granted Priority Review For Imfinzi In Limited-stage Small Cell Lung CancerAugust 15, 2024 | markets.businessinsider.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.610.46▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼102▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News HUTCHMED News Ithaca Energy News Grainger News Indivior News Bloomsbury Publishing News Global Ports News India Capital Growth News Pharos Energy News Alpha Real Trust News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AZN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZN Stock Alerts